Course Overview

Approximately 7.2 million Americans are currently living with Alzheimer’s disease, and that number is projected to nearly double by 2060. But innovations in diagnosis and treatment have the potential to change that projection if applied properly.

This interactive, gamified learning experience follows a 73-year-old patient through real-world office visits. You’ll explore how to:

Differentiate normal aging from early cognitive impairment
Address disparities in Alzheimer’s diagnosis and access to care
Apply validated cognitive screening tools appropriately
Identify appropriate candidates for biologic therapy

Credit available: 0.75 of AMA, ANCC, or AAPA

Start Program

Paul B. Rosenberg, MD

Professor of Psychiatry and Behavioral Sciences 
Johns Hopkins University School of Medicine 
Baltimore, MD 